Surgical Science Sweden AB (SUS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.09x
Surgical Science Sweden AB (SUS) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr72.89 Million) in capital expenditures (Skr6.24 Million). See Surgical Science Sweden AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
Skr72.89 Million
SEK
Capital Expenditures
Skr6.24 Million
SEK
Data as of
Dec 2025
Most recent filing
Surgical Science Sweden AB Capital Reinvestment Ratio (2015–2025)
This chart tracks Surgical Science Sweden AB's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Surgical Science Sweden AB (2015–2025)
Year-by-year Capital Reinvestment Ratio for Surgical Science Sweden AB from 2015 to 2025. For live market cap and broader valuation context, see market cap of Surgical Science Sweden AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Skr79.80 Million | Skr11.68 Million | ▼ -57.7% |
| 2024 | 0.35x | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.19x | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.27x | Skr129.49 Million | Skr34.55 Million | ▼ -27.5% |
| 2021 | 0.37x | Skr39.08 Million | Skr14.38 Million | ▼ -1.7% |
| 2020 | 0.37x | Skr23.23 Million | Skr8.69 Million | ▲ +131.8% |
| 2019 | 0.16x | Skr55.20 Million | Skr8.91 Million | ▼ -87.1% |
| 2018 | 1.26x | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 1.53x | Skr7.94 Million | Skr12.12 Million | ▲ +74.8% |
| 2016 | 0.87x | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr7.50 Million | Skr8.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow